CN105687392A - 一种活血通络酒及其制备方法 - Google Patents
一种活血通络酒及其制备方法 Download PDFInfo
- Publication number
- CN105687392A CN105687392A CN201610041678.3A CN201610041678A CN105687392A CN 105687392 A CN105687392 A CN 105687392A CN 201610041678 A CN201610041678 A CN 201610041678A CN 105687392 A CN105687392 A CN 105687392A
- Authority
- CN
- China
- Prior art keywords
- blood
- wine
- radix
- collateral
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims description 8
- 239000003814 drug Substances 0.000 claims abstract description 52
- 238000011282 treatment Methods 0.000 claims abstract description 32
- 208000007875 Femur Head Necrosis Diseases 0.000 claims description 33
- 241000180649 Panax notoginseng Species 0.000 claims description 18
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 18
- 241000522620 Scorpio Species 0.000 claims description 18
- 210000001320 hippocampus Anatomy 0.000 claims description 18
- 239000009490 scorpio Substances 0.000 claims description 18
- 241000271039 Agkistrodon Species 0.000 claims description 17
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 63
- 210000004369 blood Anatomy 0.000 abstract description 60
- 230000000694 effects Effects 0.000 abstract description 35
- 229940079593 drug Drugs 0.000 abstract description 13
- 230000003213 activating effect Effects 0.000 abstract description 8
- 230000004069 differentiation Effects 0.000 abstract description 3
- 241000133134 Saussurea Species 0.000 abstract description 2
- 244000189799 Asimina triloba Species 0.000 abstract 1
- 235000006264 Asimina triloba Nutrition 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 101000831205 Danio rerio Dynein axonemal assembly factor 11 Proteins 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 102100024282 Dynein axonemal assembly factor 11 Human genes 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241001559542 Hippocampus hippocampus Species 0.000 abstract 1
- 101000831210 Homo sapiens Dynein axonemal assembly factor 11 Proteins 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 240000009235 Rubia cordifolia Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 241000271897 Viperidae Species 0.000 abstract 1
- 235000019996 baijiu Nutrition 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 230000002146 bilateral effect Effects 0.000 description 39
- 208000002193 Pain Diseases 0.000 description 31
- 210000003128 head Anatomy 0.000 description 28
- 210000001624 hip Anatomy 0.000 description 27
- 210000004185 liver Anatomy 0.000 description 27
- 210000003205 muscle Anatomy 0.000 description 27
- 210000003734 kidney Anatomy 0.000 description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 24
- 210000003141 lower extremity Anatomy 0.000 description 24
- 238000007689 inspection Methods 0.000 description 23
- 201000010099 disease Diseases 0.000 description 22
- 210000004394 hip joint Anatomy 0.000 description 20
- 210000000988 bone and bone Anatomy 0.000 description 19
- 238000002595 magnetic resonance imaging Methods 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 206010062717 Increased upper airway secretion Diseases 0.000 description 13
- 238000003745 diagnosis Methods 0.000 description 13
- 208000026435 phlegm Diseases 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 206010021118 Hypotonia Diseases 0.000 description 12
- 208000017561 flaccidity Diseases 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 11
- 208000012285 hip pain Diseases 0.000 description 11
- 206010010904 Convulsion Diseases 0.000 description 10
- 206010031252 Osteomyelitis Diseases 0.000 description 10
- 230000036461 convulsion Effects 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 210000002435 tendon Anatomy 0.000 description 8
- 210000003462 vein Anatomy 0.000 description 8
- 206010052428 Wound Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 206010028851 Necrosis Diseases 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 238000002405 diagnostic procedure Methods 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 238000003748 differential diagnosis Methods 0.000 description 6
- 210000002414 leg Anatomy 0.000 description 6
- 230000017074 necrotic cell death Effects 0.000 description 6
- 208000037920 primary disease Diseases 0.000 description 6
- 230000007958 sleep Effects 0.000 description 6
- 230000000391 smoking effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000010392 Bone Fractures Diseases 0.000 description 5
- 206010017076 Fracture Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 241000219000 Populus Species 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 235000021271 drinking Nutrition 0.000 description 5
- 230000000302 ischemic effect Effects 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 230000003387 muscular Effects 0.000 description 5
- 230000002040 relaxant effect Effects 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 206010049816 Muscle tightness Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 238000005452 bending Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 238000012669 compression test Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 206010029410 night sweats Diseases 0.000 description 4
- 230000036565 night sweats Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000001612 separation test Methods 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010002027 Amyotrophy Diseases 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 206010009346 Clonus Diseases 0.000 description 3
- 208000034656 Contusions Diseases 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- 206010018498 Goitre Diseases 0.000 description 3
- 206010025421 Macule Diseases 0.000 description 3
- 241000475481 Nebula Species 0.000 description 3
- 206010043376 Tetanus Diseases 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 230000035606 childbirth Effects 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 230000005059 dormancy Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 210000001255 hallux Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 208000013210 hematogenous Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 229940126701 oral medication Drugs 0.000 description 3
- 238000002559 palpation Methods 0.000 description 3
- 210000004417 patella Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 210000004197 pelvis Anatomy 0.000 description 3
- 238000009527 percussion Methods 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000000069 prophylactic effect Effects 0.000 description 3
- 210000000453 second toe Anatomy 0.000 description 3
- 230000002048 spasmolytic effect Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- 230000021542 voluntary musculoskeletal movement Effects 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010001526 Air embolism Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 208000031814 IgA Vasculitis Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 241000131808 Scolopendra Species 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003099 femoral nerve Anatomy 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 210000000527 greater trochanter Anatomy 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 108010048734 sclerotin Proteins 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 240000000425 Chaenomeles speciosa Species 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 206010010214 Compression fracture Diseases 0.000 description 1
- 206010011951 Decompression Sickness Diseases 0.000 description 1
- 241001505404 Deinagkistrodon acutus Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 208000003241 Fat Embolism Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 241001522392 Halidesmus scapularis Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001478424 Hippocampus kuda Species 0.000 description 1
- 241001559417 Hippocampus trimaculatus Species 0.000 description 1
- 206010023204 Joint dislocation Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001481692 Mesobuthus martensii Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034246 Pelvic fractures Diseases 0.000 description 1
- 206010034944 Photokeratitis Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 241001373816 Saussurea laniceps Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000800405 Spatholobus suberectus Species 0.000 description 1
- 241001247203 Syngnathidae Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 210000000588 acetabulum Anatomy 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000002436 femur neck Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- -1 hemostasis Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000001981 hip bone Anatomy 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000010181 polygamy Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开了一种活血通络酒,它是由木瓜、鸡血藤、续断、茜草、全虫、杜仲、海马、三七、白花蛇、雪莲、白酒按照一定的重量配比制成,以酒的活性、温性带药物达到病灶,以活血祛风通络、除湿为主的中药组方,根据辨证论治,治疗效果显著。
Description
技术领域
本发明涉及一种治疗股骨头坏死的中药酒,具体涉及一种活血通络酒,本发明还涉及该活血通络酒的制备方法。
背景技术
股骨头坏死又称股骨头缺血性坏死,为常见的骨关节病之一,大多数因风湿病、血液病、外伤、烧伤等疾患引起,服用激素药物,过度酗酒等,先破坏临近关节面组织的血液供应,进而造成坏死。导致股骨头坏死的病因有1、现在比较常见的有外伤性:股骨头囊内骨折、股骨颈骨折、髋关节脱位、髋臼骨折、股骨头压缩性骨折、髋关节扭挫伤等。2、因长期服用激素药物导致股骨头坏死,气管炎哮喘,风湿、类风湿,皮肤病,过敏性紫癜,经常食用使用激素喂养的鸡、猪、鸭等家禽,其所含激素量都很高。3、因长期饮酒,使酒精刺激导致股骨头坏死,造成酒精在体内的积聚导致血脂增高和肝功能损害,因而使血管堵塞,出血或脂肪栓塞造成股骨头缺血性坏死。4、因风寒湿所导致的股骨头坏死形成骨蚀症,常见髋关节疼痛,寒湿为甚,下蹲困难。5、肝肾亏虚,导致股骨头坏死;肝肾功能很重要,年轻人头发早白,主要是肝肾血虚,酒精也导致肝肾亏虚,阴虚内热,其表现午后低热疼有定处,消瘦、盗汗、乏力、酸痛,不能负重易骨折,经常扭腰等等。
股骨头坏死非创伤性的致病因素可分为四个方向:1、长期服用激素,大约占总人数的43%;2、酒精中毒的占比农村高于城市;3、减压病:潜水作业、飞行人员,在高压情况下,血流和组织中溶解的氮增加,已溶解的超量氮需逐渐经肺部排出。若压力降低过快,氮气来不及排出,即在体内游离出来形成气泡,产生气体栓塞;气体栓塞在血管,血流受阻、股骨头局部血供变差形成缺血,促使股骨头坏死;4、还有患有高血压、糖尿病、动脉硬化、过度肥胖、痛风、放射治疗、挫伤等均可引起股骨头坏死。
股骨头坏死的临床症状主要有:1、疼痛特点:患有股骨头坏死之后,初期是髋骨根部前后疼痛,尤其是大腿根部内侧疼痛为其特点。开始是间歇痛,以后是持续性疼痛,活动增多时疼痛加重,休息后缓解。其二是髋关节活动功能障碍。如伸、屈、外展、内收、旋转等。不能搭上“二郎腿”,盘不上腿,继而走路出现跛行,大腿肌肉萎缩,不能下蹲等症状。2、跛行:是股骨头坏死的主要临床表现之一。引起跛行的原因主要有三点:疼痛、功能受限和患肢短缩。
目前现有技术中用于治疗股骨头坏死的药物见效慢,治疗效果不明显,易容易反复,难以根治,给患者带来了极大的痛苦,中医治疗股骨头坏死有自己的原则,重则治标,缓则治本,标本兼治,给股骨头患者带来康复的希望。
发明内容
本发明的目的在于提供一种活血通络酒,该活血通络酒以酒的活性、温性带药物达到病灶,以活血祛风通络、除湿为主的中药组方,根据辨证论治,治疗效果显著,对于股骨头坏死具有疗效确切、安全方便、标本兼治、不易复发的特点,并且酒,素有“百药之长"之称,将强身健体的中药与酒"溶"于一体的药酒,不仅配制方便、药性稳定、安全有效,而且因为酒精是一种良好的半极性有机溶剂,中药的各种有效成分都易溶于其中,药借酒力、酒助药势而充分发挥其效力,提高疗效。
本发明的另一目的是提供该活血通络酒的制备方法。
发明人在多年的临床医疗实践中,观察到股骨头坏死给患者带来的痛苦,根据该病症的发展规律,以及中药的配伍原则,并通过大量的临床验证,反复探索总结出一种活血通络酒的新配方,本发明选择木瓜、鸡血藤、续断、茜草、全虫、杜仲、海马、三七、白花蛇、雪莲、白酒进行组合,将这些药物组合使得各药物功效产生协同作用,使之具有活血祛风、通络除湿的功效,从而能够有效治疗股骨头坏死。
本发明中药物的作用:
其中:
木瓜:为蔷薇科植物贴梗海棠Chaenomelesspeciosa(Sweet)Nakai的干燥近成熟果实。性味:酸、温。归肝、脾经。功效:舒筋活络、和胃化湿。木瓜有较好的舒筋活络的作用,又能除湿止痹痛,为治湿痹、筋脉拘急之要药。治风湿痹痛时一般用于腰膝酸痛者居多,常与虎骨等配用。
鸡血藤:为豆科Leguminosae植物密花豆SpatholobussuberectusDunn的干燥藤茎。性味:苦、甘,温。归肝、肾经。功效:补血,活血,通络。本品行血养血,舒筋活络,为治疗经脉不畅,络脉不和病证的常用药。治中风手足麻木,肢体瘫痪,常配伍益气活血通络药,如黄芪、太子参等药;治血虚不养筋之肢体麻木及血虚萎黄,多配益气补血药之黄芪、当归等药用。
续断:为川续断科植物川续断DipsacusasperoidesC.Y.ChengetT.M.Ai(或DipsacusasperWall)的干燥根。性味:苦、辛、微温。归肝、肾经。功效:补肝肾;强筋骨;调血脉;止崩漏,杜仲与续断均能补肝肾,强筋骨,用于治疗肝肾不足,筋骨不健及痹证日久,常相须为用,但是杜仲兼治肾阳不足之阳痿、小便频数等,而续断又能续折伤,用于跌打损伤、扭挫伤及骨折等。治腰背酸痛,足膝无力,胎漏,崩漏,带下,遗精,跌打损伤,金疮,痔漏,痈疽疮肿。本品甘温助阳,辛温散寒,用治肾阳不足,下元虚冷,兼有补益肝肾,强健壮骨,通利血脉之功。
茜草:为茜草科植物茜草RubiacordifoliaL.的干燥根及根茎。性味:苦,寒。归肝经。功效:凉血,止血,祛瘀,通经。用于吐血,衄血,崩漏,外伤出血,经闭瘀阻,关节痹痛,跌扑肿痛。临床应用:用于血热妄行之多种出血证。茜草性寒入血分,能凉血止血,且能化瘀。凡血热妄行之出血证均可选用,兼瘀者尤宜。
全虫:又称全蝎,为钳蝎科动物东亚钳蝎ButhusmartensiiKarsch的干燥体。性味:辛,平;有毒。归肝经。功效:息风镇痉,攻毒散结,通络止痛。用于小儿惊风,抽搐痉挛,中风口歪,半身不遂,破伤风,风湿顽痹,偏正头痛,疮疡,瘰疬。临床应用:治疗痹痛,不仅有较好的止痛作用,而且对患处发麻亦有效。本品既能解毒散毒,又能通络止痛,不论内服外用,均可配用。常与蜈蚣、僵蚕同用。本品加热至100℃,30min,毒素即可消除。全蝎主入肝经,既能平息肝风,又搜风通络,具有良好的息风止痉作用,可用于治疗各种原因导致的痉挛抽搐。
杜仲:为杜仲科植物杜仲(EucommiaulmoidesOliver)的干燥树皮。性味:甘,温。归肝、肾、胃经。功效:补益肝肾、强筋壮骨、调理冲任、固经安胎。《本草纲目》:杜仲,古方只知滋肾,惟王好古言是肝经气分药,润肝燥,补肝虚,发昔人所未发也。盖肝主筋,肾主骨,肾充则骨强,肝充则筋健,屈伸利用,皆属于筋。
海马:为海龙科动物线纹海马HippocampuskelloggiJordanetSnyder、刺海马HippocampushistrixKaup、大海马HippocampuskudaBleeker、三斑海马HippocampustrimaculatusLeach或小海马(海蛆)HippocampusjaponicusKaup的干燥体。性味:甘,温。归肝、肾经。功效:温肾壮阳,散结消肿。用于阳痿,遗尿,肾虚作喘,症瘕积聚,跌扑损伤;外治痈肿疔疮。《纲目》:暖水藏,壮阳道,消瘕块,治疔疮肿毒。
三七:为五加科植物三七Panaxnotoginseng(Burk.)F.H.Chen的干燥根。性味:甘、微苦、温。归肝、胃经。功效:散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹剌痛,跌扑肿痛。《本草求真》中记载:“三七,世人仅知功能止血住痛,殊不知痛因血瘀则疼作,血因敷散则血止。三七气味苦温,能于血分化其血瘀”。
白花蛇:五步蛇Agkistrodonacutus(Gunther)的幼蛇干燥尸体。性味:甘、咸,温;有毒。归肝经。功效:祛风,通络,止痉。用于风湿顽痹,麻木拘挛,中风口歪,半身不遂,抽搐痉挛,破伤风,麻风疥癣,瘰疬恶疮。(1)对风湿痹痛、筋脉拘急等症,可配伍豨签草、独活、威灵仙等药同用;治口眼喎斜、语言蹇涩,或筋脉挛急、肌肉麻痹等症,可与全蝎、当归、羌活、白芷等配伍应用,或浸酒服。治破伤风,痉挛抽搐及小儿惊风痉厥,配伍乌梢蛇、蜈蚣等药同用。此外,白花蛇又可用于痲疯,疥癣,具有祛风攻毒之效,可与乌梢蛇、雄黄等药同用。
雪莲:菊科风毛菊属植物绵头雪莲花SaussurealanicepsHand.-Mazz.和毛头雪莲花S.eriocephalaFranch,以带根全草入药。性味:甘、微苦,温。入肝、脾、肾三经。功效:补肾壮阳,调经止血。用于雪盲,牙痛,风湿性关节炎,阳痿,月经不调,崩漏,白带;外用治创伤出血。
本发明的方解是:方中木瓜舒筋活络,鸡血藤补血活血,续断补肝肾强筋骨,茜草凉血祛瘀,全虫息风止痉、通络止痛,以上五味共为君药,注重活息风止痉、通络止痛、舒筋活络,从患者身体的根本上进行调理,所谓通则不痛,经络疏通则病痛自除,中医学认为,肾藏精,精生髓,髓藏于骨腔之中,髓养骨,肾精充足,髓化生有源,骨质得养,从身体的根本上进行调理,使病患可以根除。杜仲补肝益肾,海马温肾壮阳,三七消肿定痛,白花蛇通络止痉,雪莲补肾壮阳。以上几味共为臣药,臣药不仅在药效上对君药起到辅助作用,还可以温经通脉、熄风镇痉,可以缓解股骨头坏死所带来的麻木、疼痛的感觉,减轻患者的不适感。此药方酒的活性,温性带药物达到病灶,以活血祛风通络、除湿为主的中药组方,根据辨证论治,治疗效果显著,能够有效的治疗股骨头坏死。
本发明药物原料用量是经发明人进行大量摸索总结得出的,各原料用量为在下述重量份范围都具有较好的疗效:木瓜40-60g、鸡血藤20-40g、续断10-30g、茜草40-60g、全虫10-30g、杜仲20-40g、海马10-30g、三七20-40g、白花蛇1-5g、雪莲2-6g、白酒4000-6000g。
其中优选为:木瓜50g、鸡血藤30g、续断20g、茜草50g、全虫20g、杜仲30g、海马20g、三七30g、白花蛇3g、雪莲4g、白酒5000g。
一种活血通络酒,其制备方法如下:
步骤一:按本发明重量配比,先将木瓜在-15℃下冷冻干燥,然后进行敲击粉碎;
步骤二:按本发明重量配比,将续断、茜草、杜仲、三七切成3毫米厚的薄片,将鸡血藤切成3厘米长碎段,和完整的全虫、海马、白花蛇,完整的雪莲以及步骤一中的药块,一起放入60度10斤白酒内浸泡10天,既得本发明所述的治疗股骨头坏死的活血通络酒。
本发明药物具有温经通脉、熄风镇痉、温补肝肾的功效,且疗效确切、安全方便、标本兼治、不易复发,据对临床150例患者观察统计,使用本发明药物一个疗程总有效率90%,两个疗程总有效率97.3%。
附图说明
图1为病例一中张某初诊时期2015年3月正位股骨头X光片检查图。
图2为病例一中张某治疗时期2015年7月正位股骨头X光片检查图。
图3为病例一中张某初诊时期2015年3月MRI片检查图。
图4为病例一中张某初诊时期2015年3月MRI片检查图。
图5为病例一中张某初诊时期2015年3月MRI片检查图。
图6为病例一中张某初诊时期2015年3月MRI片检查图。
图7为病例一中张某治疗时期2015年4月MRI片检查图。
图8为病例一中张某治疗时期2015年4月MRI片检查图。
图9为病例一中张某治疗后期2015年7月MRI片检查图。
图10为病例一中张某治疗后期2015年7月MRI片检查图。
图11为病例二中丁某患病时期2015年4月正位、蛙式位股骨头X光片检查图。
图12为病例二中丁某治疗时期2015年10月正位、蛙式位股骨头X光片检查图。
图13为病例二中丁某治疗时期2015年10月蛙式位股骨头X光片检查图。
图14为病例二中丁某治疗时期2015年10月正位股骨头X光片检查图。
图15为病例三中杨某初诊时期2015年3月正位股骨头X光片检查图。
图16为病例三中杨某初诊时期2015年3月蛙式位股骨头X光片检查图。
图17为病例三中杨某治疗时期2015年8月正位股骨头X光片检查图。
图18为病例三中杨某治疗时期2015年8月蛙式位股骨头X光片检查图。
具体实施方式
实施例一、木瓜40g、鸡血藤20g、续断10g、茜草40g、全虫10g、杜仲20g、海马10g、三七20g、白花蛇1g、雪莲2g、白酒4000g。
实施例二、木瓜50g、鸡血藤30g、续断20g、茜草50g、全虫20g、杜仲30g、海马20g、三七30g、白花蛇3g、雪莲4g白酒5000g。
实施例三、木瓜60g、鸡血藤40g、续断30g、茜草60g、全虫30g、杜仲40g、海马30g、三七40g、白花蛇5g、雪莲6g、白酒6000g。
下面是患者使用本发明药物的临床统计资料:
一、一般资料
收治门诊患者150例,其中男性89例,女性61例,男女比例1.4:1,年龄最大者73岁,年龄最小者30岁,平均年龄47岁,病程几天年到几周不等。患者年龄、性别、病程等各项基本资料基本相同,差异无统计学意义(P>0.05)。
二、诊断标准
1、体格检查:一般“4”字试验,向下压痛为阳性;
2、X线平片检查:髋关节正位片、蛙式位片;
3、MRI扫描检查,确诊程度更高;
4、CT检查:它发现股骨头坏死灶的时间较MRI晚,在股骨头坏死的早起期CT片可表现正常。CT扫描对判断股骨头内骨质改变优于MRI,对明确股骨头坏死诊断后进行塌陷的预测有重要意义。
三、治疗方法:
按照本发明药物实施例二,以及优选的制备方法制成的活血通络酒,毎日早晚饭后温服15ml。
四、疗效评定标准:
治愈:临床自觉症状消失,关节活动恢复正常,X线片,磁共振:股骨头密度均匀,骨小梁排列整齐,骨质修复整片。
好转:临床自觉症状消失,髋关节功能基本恢复,X线片、磁共振:骨质破坏修复好。
无效:临床自觉症状X先检查均无变化。
五、治疗结果统计
其中:总有效率=治愈率+好转率
通过治疗结果的统计表明,本发明中药在治疗股骨头坏死方面具有良好的临床效果,能有效提高治疗的治愈率,值得在临床应用上推广。
典型病例及疗效:
病例一、患者张某,女,40岁,入院时间2015.3.28。
主诉:双髋部疼痛伴活动受限3天,加重1天。
现病史:患者3天前无明显诱因出现双髋部疼痛,疼痛时轻时重伴跛行步态,休息后症状改善。曾到中医院就诊,行双髋MRI诊断为“双侧股骨头缺血性坏死”。当日双髋部疼痛加重,遂来我院就诊,门诊以“双侧股骨头缺血性坏死”收入院。现无胸闷心慌,无发热盗汗,素颜可,眠可,二便调。
既往史:否认肝炎、伤寒、结核等传染病史,否认糖尿病、心脏病、高血压病等慢性病及其他重大疾病史。否认外伤、手术及输血史,预防接种随当地,否认药物及食物等的过敏史。
个人史:生于本地,长于本地,无外地久居史,未到过疫区。生活居住条件可,无烟酒嗜好,否认其他不良嗜好。
月经史:初潮14岁,经量正常,颜色鲜红,无血块。
生育史:适龄婚育,育有2子,配偶及子女均体健,家庭关系和睦。
家族史:否认有家族遗传病史。
中医望、闻、切诊:患者痛苦面容,语声有力,气息匀称,全身皮肤润泽无斑疹,肌肤无黄染,皮下筋脉无迂曲,无口眼歪斜,目睛无云翳,颈项无瘿瘤,瘰疬,舌质淡,苔少,脉佃数。
专科检查:脊柱生理曲度可,无明显侧弯及畸形、压痛,活动度可;双髋关节无红热肿,双侧“4”字试验(+),双侧腹股沟中点压痛(+),骨盆挤压分离试验(-),双侧托马氏征(-)。双髋关节活动度:右下肢曲髋100°,后伸20°,内旋20°、外旋35°、外展30°、内收20°;左下肢曲髋110°,后伸20°,内旋25°、外旋40°、外展30°、内收20°;双下肢力线(髂前上棘于足第一、二趾蹼间连线)经髌骨内侧1/3,双侧股四头肌肌力为5级,双侧踇背伸肌肌力5级,双下肢肌张力正常,肢端感觉血运活动可。余肢无异常。
辅助检查:2015-03-28中医院骨盆DR片示:右侧股骨头缺血性坏死。2015-03-28中医院骨盆MRI片示:双侧股骨头缺血性坏死。
初步诊断:中医诊断:骨蚀病、阴虚内热。
西医诊断:双侧股骨头缺血性坏死。
中医辨病辩证依据:综合四诊,本病当属祖国医学“骨蚀病”范畴,证属“阴虚内热”,患者女性,平素无烟酒嗜好,过时肥甘,肥甘性日久而致湿热蕴结,脉络堵塞,筋骨失养;故血虚而生热,热擅走窜,过度肥甘则肝阳炽盛,耗伤阴血,血受煎熬而成血瘀,瘀血阻滞而使痰浊内生,痰饮内停又加重瘀血。致痰瘀互结,局部经络不通,气血瘀滞,血行不畅。经脉不通,故不通则痛;经络不通致筋挛骨痹,则关节活动不利。综合四诊,该患者病位在髋部,辩病为骨蚀病,辨证属阴虚內热丶痰瘀阻络证。
中医鉴别诊断:本病目前诊断明确,需与痿症相鉴别,痿症多是外伤或正气亏虚导致肢体筋脉弛缓、肌肉肥胖、手足痿软无力及麻木为特征,临床常见下肢痿弱,步履艰难,甚至不能随意运动为多见。本患者症状以髋关节疼痛为主,无明显肌肉萎缩、手足无力症状,故可鉴别。
治疗:木瓜50g、鸡血藤30g、续断20g、茜草50g、全虫20g、杜仲30g、海马20g、三七30g、白花蛇3g、雪莲4g、白酒5000g。
白酒60度10斤浸泡10天后,毎日早晚饭后温服15ml。
图1、图2是患者治疗后X光片检查图。
图3-图10是患者治疗后MRI片检查图。
其中一次查房记录:
患者神志清,精神可,自诉双髋部现以不疼,饮食正常,二便调,睡眠可。查体:双髋关节无红热肿,双侧股骨沟重点深压痛减轻,双侧大粗隆叩击痛减轻,双侧“4”字试验弱阳性,双髋关节活动度:右下肢曲髋105°,后伸25°,内旋20°、外旋35°、外展35°、内收25°;左下肢曲髋110°,后伸25°,内旋25°、外旋40°、外展30°、内收20°。医师查房,嘱继续应用继续服用药酒,密切观察病情变化。
出院情况:患者神志清,精神可,饮食正常,二便调,睡眠可,双髋疼痛不适感较入院前明显好转。
随访自述双侧髋关节不痛,行走正常,复查结果正常,根据股骨头坏死康复标准,以达到基本痊愈。
病例二、患者丁某,男,48岁,发病节气:夏至第6天。
主诉:双侧股骨头坏死1年。
现病史:患者1年前自觉双髋部疼痛,疼痛时跛行步态,负重行走时疼痛加重,休息后症状改善。后经市人民医院行影像学检查后诊断为“双侧股骨头坏死”。曾自行口服药物、外敷膏药等保守治疗(具体不详),效果欠佳;近日又出现双髋部疼痛,不敢活动,急来我院就诊,门诊以“双侧股骨头坏死”收入院。现无胸闷心慌,无发热盗汗,素颜可,眠可,二便调。
既往史:2009年因车祸致骨盆骨折在市医院行手术治疗(具体过程不详),否认肝炎、伤寒、结核等传染病史,否认糖尿病、心脏病、高血压病等慢性病及其他重大疾病史。否认其他外伤、手术及输血史,预防接种随当地,否认药物及食物等的过敏史。
个人史:生于本地,长于本地,无外地久居史,未到过疫区。生活居住条件可,偶饮酒吸烟,否认其他不良嗜好。
生育史:适龄婚育,育有2子,配偶及子女均体健,家庭关系和睦。
家族史:否认有家族遗传病史。
中医望、闻、切诊:患者面色正常,语声有力,气息匀称,全身皮肤润泽无斑疹,肌肤无黄染,皮下筋脉无迂曲,无口眼歪斜,目睛无云翳,颈项无瘿瘤,瘰疬,舌质淡,苔少,脉滑数。
专科检查:脊柱生理曲度可,无明显侧弯及畸形、压痛,活动度可;双髋关节无红热肿,双侧“4”字试验(+),双侧腹股沟中点压痛(+),骨盆挤压分离试验(-),双侧托马氏征(-)。双髋关节活动度:右下肢曲髋105°,后伸30°,内旋30°、外旋40°、外展30°、内收30°;左下肢曲髋100°,后伸20°,内旋25°、外旋40°、外展30°、内收20°;双下肢力线(髂前上棘于足第一、二趾蹼间连线)经髌骨内侧1/3,双侧股四头肌肌力为5级,双侧踇背伸肌肌力5级,双下肢肌张力正常,肢端感觉血运活动可。余肢无异常。
辅助检查:2015-04-22市人民医院骨盆DR片示:双侧股骨头坏死。初步诊断:中医诊断:骨蚀病、痰瘀阻络。西医诊断:双侧股骨头坏死。
中医辨病辩证依据:综合四诊,本病当属祖国医学“骨蚀病”范畴,证属“痰瘀阻络”,患者男性,平素烟酒嗜好,过时肥甘,酒性日久而致湿热蕴结,脉络堵塞,筋骨失养;辛热擅走窜,过度饮酒则肝阳炽盛,耗伤阴血,血受煎熬而成血瘀,瘀血阻滞而使痰浊内生,痰饮内停又加重瘀血。致痰瘀互结,局部经络不通,气血瘀滞,血行不畅。经脉不通,故不通则痛;经络不通致筋挛骨痹,则关节活动不利。综合四诊,该患者病位在髋部,辩病为骨蚀病,辨证属痰瘀阻络证。
中医鉴别诊断:本病目前诊断明确,需与痿症相鉴别,痿症多是外伤或正气亏虚导致肢体筋脉弛缓、肌肉消瘦、手足痿软无力及麻木为特征,临床常见下肢痿弱,步履艰难,甚至不能随意运动为多见。本患者症状以髋关节疼痛为主,无明显肌肉萎缩、手足无力症状,故可鉴别。
治疗:口服活血通络酒每日两次饭后15ml温服。处方:木瓜50g、鸡血藤30g、续断20g、茜草50g、全虫20g、杜仲30g、海马20g、三七30g、白花蛇3g、雪莲4g、白酒5000g。
60度白酒10浸泡10天后服。
图11-图14是患者治疗前后X光片检查图。
其中一次查房记录:
患者神志清,精神可,自诉双髋部疼痛减轻,饮食正常,二便调,睡眠可。查体:双髋关节无红热肿,双侧股骨沟重点深压痛减轻,双侧大粗隆叩击痛减轻,双侧“4”字试验弱阳性,双髋关节活动度:右下肢曲髋110°,后伸30°,内旋30°、外旋40°、外展30°、内收30°;左下肢曲髋105°,后伸25°,内旋25°、外旋40°、外展35°、内收25°。双侧股四头肌肌力为5级,双侧踇背伸肌肌力5级,双下肢肌张力正常,肢端感觉血运活动可。主任医师查房,嘱继续使用上述方法治疗,密切观察病情变化。
出院情况:患者神志清,精神可,饮食正常,二便调,睡眠可,双髋疼痛不适感较入院前明显好转。
出院后随访多次,患者的情况好转,现在情况稳定,无疼痛感,拍片检查正常,根据股骨头坏死康复标准,以达到基本痊愈。
病例三、患者杨某,男,68岁,发病节气:惊蛰第10天。
主诉:右髋部疼痛12年,加重5天。
现病史:患者于12年前无明显诱因出现右髋部疼痛,负重行走时疼痛加重,并逐渐于近8年出现右下肢跛行,休息后症状稍改善。3年前曾在华方医院检查后诊断为:右股骨头坏死,曾行口服药物、针灸等保守治疗(具体不详),近5天来症状加重,不能自行,急来我院就诊,门诊以“双侧股骨头坏死”收入院。现无胸闷心慌,无发热盗汗,素颜可,眠可,二便调。
既往史:19年前患过敏性紫癜,行激素治疗;高血压病病史10年,最高170/110mmHg,口服利血平、罗布麻等药物治疗。否认肝炎、伤寒、结核等传染病史,否认糖尿病、心脏病等慢性病及其他重大疾病史。否认有外伤及输血史,预防接种随当地,有链霉素过敏史,否认食物等的过敏史。
个人史:生于济宁,长于济宁,在日照工作,未到过疫区。偶饮酒,吸烟30年:20支/日,否认其他不良嗜好。
生育史:适龄婚育,育有2女1子,配偶及子女均体健,家庭关系和睦。
家族史:否认有家族遗传病史。
中医望、闻、切诊:患者面色正常,语声有力,气息匀称,全身皮肤润泽无斑疹,肌肤无黄染,皮下筋脉无迂曲,无口眼歪斜,目睛无云翳,颈项无瘿瘤,瘰疬,舌质淡,苔少,脉沉细无力。
专科检查:脊柱生理曲度可,无明显侧弯及畸形,活动度可;双髋关节无红热肿,双侧“4”字试验(+),双侧腹股沟中点压痛(+),骨盆挤压分离试验(+),双侧侧股神经牵拉试验(+)。右髋关节叩击痛,双髋关节活动度:右下肢曲髋100°,后伸10°,内旋20°、外旋5°、外展25°、内收5°;左下肢曲髋120°,后伸20°,内旋30°、外旋10°、外展30°、内收10°;双下肢力线(髂前上棘于足第一、二趾蹼间连线)经髌骨内侧1/3,双侧股四头肌肌力、双侧踇背伸肌肌力、双下肢肌张力正常,肢端感觉血运活动可。余肢无异常。
辅助检查:2015-03-15双髋DR及双髋MRI片示:双侧股骨头坏死。
初步诊断:中医诊断:骨蚀病、痰瘀阻络。西医诊断:1、双侧股骨头缺血性坏死,2.高血压病。
中医辨病辩证依据:综合四诊,本病当属祖国医学“骨蚀病”范畴,证属“痰瘀阻络”,患者男性,平素烟酒嗜好,过时肥甘,酒性日久而致湿热蕴结,脉络堵塞,筋骨失养;辛热擅走窜,过度饮酒则肝阳炽盛,耗伤阴血,血受煎熬而成血瘀,瘀血阻滞而使痰浊内生,痰饮内停又加重瘀血。致痰瘀互结,局部经络不通,气血瘀滞,血行不畅。经脉不通,故不通则痛;经络不通致筋挛骨痹,则关节活动不利。综合四诊,该患者病位在髋部,辩病为骨蚀病,辨证属痰瘀阻络证。
中医鉴别诊断:本病目前诊断明确,需与痿症相鉴别,痿症多是外伤或正气亏虚导致肢体筋脉弛缓、肌肉消瘦、手足痿软无力及麻木为特征,临床常见下肢痿弱,步履艰难,甚至不能随意运动为多见。本患者症状以髋关节疼痛为主,无明显肌肉萎缩、手足无力症状,故可鉴别。
治疗:口服活血通络酒每日两次饭后15ml温服。处方:木瓜50g、鸡血藤30g、续断20g、茜草50g、全虫20g、杜仲30g、海马20g、三七30g、白花蛇3g、雪莲4g、白酒5000g。
60度白酒10浸泡10天后服。
图15-图18是患者治疗前后X光片检查图。
其中一次查房记录:
患者神志清,精神可,自诉双髋部疼痛明显减轻,饮食正常,二便调,睡眠可。查体:双髋关节无红热肿,双侧“4”字试验弱阳性,双侧腹股沟中点压痛弱阳性,骨盆挤压分离试验弱阳性,双侧侧股神经牵拉试验弱阳性,双髋关节活动度:右下肢曲髋110°,后伸10°,内旋20°、外旋15°、外展30°、内收15°;左下肢曲髋125°,后伸20°,内旋30°、外旋15°、外展30°、内收10°。今日主任医师查房,嘱继续服用上述药物,双髋关节局部按摩,密切观察病情变化。
出院情况:患者神志清,精神可,饮食正常,二便调,睡眠可,双髋无疼痛感,可以自行。
出院后随访多次,患者的情况好转,现在情况稳定,无疼痛感,拍片检查正常,根据股骨头坏死康复标准,以达到基本痊愈。
Claims (3)
1.一种活血通络酒,其特征在于,该活血通络酒是由以下重量份的药物制成:木瓜40-60g、鸡血藤20-40g、续断10-30g、茜草40-60g、全虫10-30g、杜仲20-40g、海马10-30g、三七20-40g、白花蛇1-5g、雪莲2-6g、白酒4000-6000g。
2.根据权利要求1所述的活血通络酒,其特征在于,由以下重量份的药物制成:木瓜50g、鸡血藤30g、续断20g、茜草50g、全虫20g、杜仲30g、海马20g、三七30g、白花蛇3g、雪莲4g、白酒5000g。
3.一种活血通络酒的制备方法,其特征在于,制备方法如下:步骤一:按本发明重量配比,先将木瓜在-15℃下冷冻干燥,然后进行敲击粉碎;步骤二:按本发明重量配比,将续断、茜草、杜仲、三七切成3毫米厚的薄片,将鸡血藤切成3厘米长碎段,和完整的全虫、海马、白花蛇,完整的雪莲以及步骤一中的药块,一起放入60度10斤白酒内浸泡10天,既得本发明所述的治疗股骨头坏死的活血通络酒。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610041678.3A CN105687392A (zh) | 2016-01-22 | 2016-01-22 | 一种活血通络酒及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610041678.3A CN105687392A (zh) | 2016-01-22 | 2016-01-22 | 一种活血通络酒及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105687392A true CN105687392A (zh) | 2016-06-22 |
Family
ID=56228439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610041678.3A Pending CN105687392A (zh) | 2016-01-22 | 2016-01-22 | 一种活血通络酒及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105687392A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107325937A (zh) * | 2017-07-17 | 2017-11-07 | 荆楚理工学院 | 一种养生保健药酒及其制备工艺 |
-
2016
- 2016-01-22 CN CN201610041678.3A patent/CN105687392A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107325937A (zh) * | 2017-07-17 | 2017-11-07 | 荆楚理工学院 | 一种养生保健药酒及其制备工艺 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100584369C (zh) | 一种外用治疗痹症中药组合物 | |
| CN101337059A (zh) | 一种治疗骨质增生的膏药及其制备方法 | |
| CN101293041B (zh) | 一种治疗腰椎间盘突出、椎管狭窄的外用药物 | |
| CN103479819B (zh) | 中药熏灸疗法治疗类风湿性关节炎的中药组方 | |
| CN101322756B (zh) | 用于推拿按摩治疗腰椎病症的药物及其制备方法 | |
| CN105687392A (zh) | 一种活血通络酒及其制备方法 | |
| CN103585483B (zh) | 一种治疗膝骨性关节病的中药组合物及其制备方法 | |
| CN105343221A (zh) | 一种治疗腰腿痛的中药组合物 | |
| CN106138436A (zh) | 一种治疗腰椎间盘突出和骨质增生的中药及其制备方法 | |
| CN105497779A (zh) | 用于治疗急性腰扭伤的中药膏药 | |
| CN103432328B (zh) | 中药熏灸疗法治疗股骨头坏死的中药组合物 | |
| CN104740003A (zh) | 一种治疗腰椎间盘突出的中药 | |
| CN109806351A (zh) | 颈肩腰腿痛温敷散 | |
| CN109758556A (zh) | 一种治疗股骨头缺血性坏死的中药组合物及应用 | |
| CN101204533B (zh) | 腰突回位胶囊结合倒退行走治疗腰椎间盘突出症 | |
| CN105687786A (zh) | 一种股骨复原汤及其制备方法 | |
| CN104399035B (zh) | 一种用于治疗强直性脊柱炎的中药 | |
| CN104815312A (zh) | 一种用于腰椎椎管狭窄术后护理的中药制剂及制备方法 | |
| CN106344896A (zh) | 一种治疗风湿病、颈椎病和腰椎间盘突出症的中药 | |
| CN103611047B (zh) | 一种用于治疗脾肾虚弱型尿路结石的中药组合物 | |
| CN105833040A (zh) | 一种用于治疗风寒湿邪、颈腰椎疾病的中药膏药 | |
| CN105106917A (zh) | 治疗颈腰椎病的药酒 | |
| CN102078588A (zh) | 一种治疗骨质增生的药物组合物及其制备方法 | |
| CN101721499A (zh) | 一种治疗骨质疏松症的药酒 | |
| CN109674991A (zh) | 一种治疗子宫肌瘤的组合中药制剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160622 |
|
| WD01 | Invention patent application deemed withdrawn after publication |